Figure 2.
Comparison of successful clinical outcome in patients receiving ceftolozane/tazobactam (C/T) as empiric therapy in comparison with those who received C/T as targeted or rescue therapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.